
A class of medications best known for treating diabetes and obesity may also reduce the risk of addiction – and help people who already have one, a new study shows.
Semaglutide (also known as Ozempic), liraglutide and tirzepatide (Wegovy) belong to a class of drugs called GLP-1 (glucagon-like peptide-1) receptor agonists. These mimic a hormone involved in regulating blood sugar and appetite.